Patient Preference and Adherence (Apr 2021)
Differences in Lung Cancer Treatment Preferences Among Oncologists, Patients and Family Members: A Semi-Structured Qualitative Study in China
Abstract
Xiaoning He,1,2 Mengqian Zhang,1,2 Jing Wu,1,2 Song Xu,3 Xiangli Jiang,4 Ziping Wang,5 Shucai Zhang,6 Feng Xie7,8 1School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, People’s Republic of China; 2Center for Social Science Survey and Data, Tianjin University, Tianjin, People’s Republic of China; 3Department of Lung Cancer Surgery, Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, People’s Republic of China; 4Tianjin Medical University Cancer Institute & Hospital, Tianjin, People’s Republic of China; 5Department of Medical Oncology, Cancer Institute (Hospital), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People’s Republic of China; 6Department of Medical Oncology, Beijing Chest Hospital, Beijing, People’s Republic of China; 7Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada; 8Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, ON, CanadaCorrespondence: Jing WuSchool of Pharmaceutical Science and Technology, Tianjin University, No. 92 Weijin Road, Nankai District, Tianjin, 300072, People’s Republic of ChinaTel +862227405176Fax +862287401830Email [email protected]: Cancer treatment decision-making often needs to balance benefits, harms, and costs. This study sought to identify the differences in cancer treatment preference among oncologists, patients and their family members in China.Methods: A semi-structured face-to-face qualitative interview was conducted among oncologists, patients and their family members recruited in four tertiary hospitals in China. The interview guide was developed based on literature review and expert consultation. Participants were asked to indicate their preferences when making lung cancer treatment decisions. All interviews were audio-taped, transcribed verbatim, and thematic analyzed. The preferences were compared among three groups of participants.Results: A total of 17 participants (5 oncologists, 6 dyads of patients and family members) were interviewed between June and July 2019. Five themes, namely, survival benefit, adverse effect/symptom, treatment process, treatment cost, and the impact on daily life were identified. The oncologists and family members gave highest priority on survival benefit, while the patients are concerned most about treatment cost and quality of life.Conclusion: This study reveals different preferences for cancer treatment among oncologists, patients and their family members in China. Education is needed to empower patients and family members and promote share decision-making in this country.Keywords: lung cancer, preference, qualitative interview, survival benefit, cost
